Scientist Home Future Health Ltd (SHFH) stock: key figures, P/E, revenue and dividend

Materials · Hong Kong

Price
1.70 USD
Market cap
40.10 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Scientist Home Future Health Ltd financials

Fiscal year2025
Revenue204,055.00 USD
Gross profit81,887.00 USD
Operating income-231,725.00 USD
EBIT-231,725.00 USD
Net income-231,725.00 USD
Diluted EPS – continuing operations-0.01 USD

Full history since 2024, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Scientist Home Future Health Ltd

Scientist Home Future Health Limited engages in the retail trading of health supplements and topical creams in Hong Kong and internationally. The company offers Scientist Home Vein Cream, for supporting vein health; Scientist Home Calcification Cream for addressing calcification problems associated with bone, joint and muscle health, as well as the cardiovascular system; and Scientist Home Spermaceti Cream, which targets joint and muscle discomfort for arthritis, tendon and ligament strains, and minor sprains and bruises. It also provides Scientist Home Bone Gelatine Hydrolysate, a nutritional supplement which helps to maintain and enhance bone and joint health; Scientist Home Mixed Gelatine Hydrolysate, a supplement that promotes bone and joint health; and Scientist Home High Concentration Proteinase, a supplement that supports various health needs, including bone and joint discomfort, muscle tenderness, airway and lung health, digestive health, intestinal and colon health, and soft tissue injury. The company was incorporated in 2024 and is based in Kwun Tong, Hong Kong.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.